Severe myoclonic epilepsy in infancy: genes and variants

Explore variant evidence for Severe myoclonic epilepsy in infancy across 2 analyzed proteins (SCN1A, HCN1). Linked ClinVar records include 214 pathogenic or likely pathogenic variants, 33 variants of uncertain significance and 32 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.

Data updated 2026-11-05. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Severe myoclonic epilepsy in infancy

Weakly linked (only a few uncertain records): SCN9A.

Where Severe myoclonic epilepsy in infancy variants cluster

ClinVar pathogenic and likely pathogenic variants linked to Severe myoclonic epilepsy in infancy

VariantPositionProtein partClinical label
SCN1A R931H931IIPathogenic / likely pathogenic (★★★)
SCN1A R1639P1639IVPathogenic / likely pathogenic (★★★)
SCN1A G908R908IIPathogenic / likely pathogenic (★★★)
SCN1A V1637E1637IVPathogenic / likely pathogenic (★★★)
SCN1A P768L768IIPathogenic / likely pathogenic (★★★)
SCN1A P113T113IPathogenic / likely pathogenic (★★)
SCN1A M145T145IPathogenic / likely pathogenic (★★)
SCN1A A1429V1429IIIPathogenic / likely pathogenic (★★)
SCN1A R118S118IPathogenic / likely pathogenic (★★)
SCN1A G329C329IPathogenic / likely pathogenic (★★)
SCN1A G329V329IPathogenic / likely pathogenic (★★)
SCN1A P358S358IPathogenic / likely pathogenic (★★)
SCN1A V422M422IPathogenic / likely pathogenic (★★)
SCN1A L897S897IIPathogenic / likely pathogenic (★★)
SCN1A L897F897IIPathogenic / likely pathogenic (★★)
SCN1A R931L931IIPathogenic / likely pathogenic (★★)
SCN1A R931P931IIPathogenic / likely pathogenic (★★)
SCN1A R931S931IIPathogenic / likely pathogenic (★★)
SCN1A R931C931IIPathogenic / likely pathogenic (★★)
SCN1A C959R959IIPathogenic / likely pathogenic (★★)
SCN1A C959Y959IIPathogenic / likely pathogenic (★★)
SCN1A T1658P1658IVPathogenic / likely pathogenic (★★)
SCN1A T1658M1658IVPathogenic / likely pathogenic (★★)
SCN1A A1783T1783IVPathogenic / likely pathogenic (★★)
SCN1A A1783V1783IVPathogenic / likely pathogenic (★★)
SCN1A G329A329IPathogenic / likely pathogenic (★★)
SCN1A R393C393IPathogenic / likely pathogenic (★★)
SCN1A P1451L1451IIIPathogenic / likely pathogenic (★★)
SCN1A R1648C1648IVPathogenic / likely pathogenic (★★)
SCN1A R101Q101CytoplasmicPathogenic / likely pathogenic (★★)
SCN1A A104D104CytoplasmicPathogenic / likely pathogenic (★★)
SCN1A T112I112IPathogenic / likely pathogenic (★★)
SCN1A N115K115IPathogenic / likely pathogenic (★★)
SCN1A T162I162IPathogenic / likely pathogenic (★★)
SCN1A K225N225IPathogenic / likely pathogenic (★★)
SCN1A I227S227IPathogenic / likely pathogenic (★★)
SCN1A A239T239IPathogenic / likely pathogenic (★★)
SCN1A G271V271IPathogenic / likely pathogenic (★★)
SCN1A G271S271IPathogenic / likely pathogenic (★★)
SCN1A C277Y277IPathogenic / likely pathogenic (★★)
SCN1A W280R280IPathogenic / likely pathogenic (★★)
SCN1A C336Y336IPathogenic / likely pathogenic (★★)
SCN1A A342S342IPathogenic / likely pathogenic (★★)
SCN1A C345R345IPathogenic / likely pathogenic (★★)
SCN1A Y349C349IPathogenic / likely pathogenic (★★)
SCN1A D382E382IPathogenic / likely pathogenic (★★)
SCN1A F402I402IPathogenic / likely pathogenic (★★)
SCN1A V421M421IPathogenic / likely pathogenic (★★)
SCN1A Y426C426IPathogenic / likely pathogenic (★★)
SCN1A H939Y939IIPathogenic / likely pathogenic (★★)
SCN1A R946P946IIPathogenic / likely pathogenic (★★)
SCN1A G950E950IIPathogenic / likely pathogenic (★★)
SCN1A G979E979IIPathogenic / likely pathogenic (★★)
SCN1A L1287P1287IIIPathogenic / likely pathogenic (★★)
SCN1A I1347N1347IIIPathogenic / likely pathogenic (★★)
SCN1A V1350M1350IIIPathogenic / likely pathogenic (★★)
SCN1A W1358R1358IIIPathogenic / likely pathogenic (★★)
SCN1A S1362R1362IIIPathogenic / likely pathogenic (★★)
SCN1A G1365D1365IIIPathogenic / likely pathogenic (★★)
SCN1A G1421E1421IIIPathogenic / likely pathogenic (★★)

Showing 60 of 214.

Uncertain variants prioritized for review in Severe myoclonic epilepsy in infancy

VariantPositionProtein partClinical labelEvidence
SCN1A R862Q862IIConflicting reports (★)+6: 2 other pathogenic changes within 3 positions; R862G at the same position is pathogenic; REVEL 0.970
SCN1A L221V221IConflicting reports (★)+6: L221P at the same position is pathogenic; REVEL 0.936
SCN1A A1440V1440IIIConflicting reports (★)+6: 3 other pathogenic changes within 3 positions; A1440T at the same position is pathogenic; REVEL 0.865

Which prediction tools work for Severe myoclonic epilepsy in infancy

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to Severe myoclonic epilepsy in infancy

Frequently asked questions

Which genes have records linked to Severe myoclonic epilepsy in infancy?

This view contains 2 analyzed proteins: SCN1A, HCN1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 214 pathogenic or likely pathogenic variants, 33 variants of uncertain significance and 32 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 3 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 336 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center